HomeCare September 18, 2024

CCS Medical research reveals diabetes patients receiving a CGM through a medical benefit had lower costs of care, higher device adherence & longer therapy attendance

DALLAS—CCS Medical, a clinical solutions and home-delivered medical supplies provider, announced new research results which found patients living with diabetes who use a continuous glucose monitoring (CGM) device stay on therapy longer and have a lower total cost of care when they receive their supplies through a medical benefit.

The peer-reviewed study, published in the Journal of Medical Internet Research Diabetes (JMIR), used a retrospective claims analysis to demonstrate that patients receiving CGM through a medical benefit instead of a pharmacy had 35% lower average annual total costs of care and 23% higher device...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Survey / Study, Technology, Trends, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article